Invitae Corp (NVTA) News Headlines

▮ More

Date

Headline

1/30/2023 7:33:35 AM Invitae Appoints William H. Osborne To Board Of Directors

1/9/2023 7:07:23 AM Invitae Corp. Q4 Revenue $122 Mln Vs. $126 Mln Last Year

12/1/2022 7:30:00 AM Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases (Press Release)

11/11/2022 7:09:52 AM Pre-market Movers: SNAL, VS, OLMA, MTTR, HLTH…

11/9/2022 6:59:18 AM Pre-market Movers: MACK, IXHL, UPST, CARG, ELBM…

8/11/2022 7:55:28 AM Pre-market Movers: SWX, GWAV, CSSE, NVTA, SONO…

7/19/2022 8:01:18 AM Pre-market Movers: CVM, SRGA, USEA, WETG, NRGV…

6/15/2022 6:55:15 AM Pre-market Movers: REV, ASTL, VNRX, VORB, GGR…

5/19/2022 6:32:07 AM Invitae Announces Commercial Availability Of Expanded Invitae Pharmacogenomics Panel

4/4/2022 6:46:18 AM Invitae Introduces First Comprehensive Genetic Test Suite For Neurodevelopmental Disorders

4/4/2022 6:30:00 AM Invitae Introduces First Comprehensive Genetic Test Suite for Neurodevelopmental Disorders (Press Release)

3/29/2022 6:31:27 AM Invitae Announces Launch Of Invitae Digital Health

3/17/2022 6:34:13 AM Invitae Launches Full Access To Its Liquid-Based Personalized Cancer Monitoring Platform

3/2/2022 11:58:52 AM Invitae Corp. Continues Downward Spiral

2/16/2022 3:01:21 AM Invitae Reports Availability Of FusionPlex Dx And LiquidPlex Dx In Europe

1/10/2022 7:10:01 AM Invitae 2021 Revenue Up Approx. 64%; Billable Volumes Up 76% - Quick Facts

1/10/2022 7:01:41 AM Invitae Reports 64% Growth Year-over-year In FY Revenues

10/22/2021 8:07:44 AM Invitae, UCL And Francis Crick Institute Announce New Data From TRACERx Research Collaboration

9/7/2021 8:23:13 AM Invitae To Acquire Ciitizen - Quick Facts

9/7/2021 7:21:36 AM Invitae To Buy Ciitizen For About $325 Mln